Literature DB >> 16945655

Review of 86 patients with myelodysplasia and neurogenic bladder who underwent sigmoidocolocystoplasty and were followed more than 10 years.

Yutaka Hayashi1, Atsuyuki Yamataka, Kazuhiro Kaneyama, Yoshifumi Kato, Geoffrey J Lane, Takeshi Miyano.   

Abstract

PURPOSE: We reviewed the long-term outcome of sigmoidocolocystoplasty.
MATERIALS AND METHODS: The records of 86 patients who underwent sigmoidocolocystoplasty with a followup of more than 10 years were reviewed, focusing on histopathology, renal function, vesicoureteral reflux, bladder stones and urinary continence. We developed a urinary continence evaluation score, calculated as the postoperative minus the preoperative urinary continence score, including 0-incontinence, 1-severe leakage, 2-moderate leakage, 3-mild leakage, 4-almost dry and 5-dry, for patient self-assessment of urinary continence. A score of 2 or more meant improvement and a score of less than 2 meant no improvement.
RESULTS: Mean followup was 13.1 years (range 10 to 21). Histopathology showed inflammation in all cases, hyperplasia in 9 and metaplasia in 4. In 80 of 86 cases creatinine clearance was normal. Ureteral reimplantation had been performed before sigmoidocolocystoplasty in 9 cases (13 kidneys) for grades III to V vesicoureteral reflux, which recurred as grade I in 1 (1 kidney). Ureteral reimplantation was performed during sigmoidocolocystoplasty in 31 cases (58 kidneys) and grades I to II vesicoureteral recurred in 5 (6 kidneys). Of the remaining 44 sigmoidocolocystoplasty cases there were 2 (2 kidneys) of grade I vesicoureteral reflux. On (99m)technetium-dimercapto-succinic acid scintigraphy there was increased renal scarring in 8 cases. Bladder stones were identified in 18 of 86 cases during followup but they were absent at review. The urinary continence evaluation score showed improvement in 61 cases and no improvement in 25.
CONCLUSIONS: Our results suggest that sigmoidocolocystoplasty is safe and effective in the long term.

Entities:  

Mesh:

Year:  2006        PMID: 16945655     DOI: 10.1016/j.juro.2006.03.123

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


  6 in total

1.  Complete covered cloacal exstrophy.

Authors:  Masaaki Oshita; Tadaharu Okazaki; Kyeong Deok Lee; Geoffrey J Lane; Atsuyuki Yamataka
Journal:  Pediatr Surg Int       Date:  2007-10       Impact factor: 1.827

2.  Midterm outcomes of protection for upper urinary tract function by augmentation enterocystoplasty in patients with neurogenic bladder.

Authors:  Limin Liao; Fan Zhang; Guoqing Chen
Journal:  Int Urol Nephrol       Date:  2014-07-23       Impact factor: 2.370

Review 3.  Renal transplantation in augmented bladders.

Authors:  P López Pereira; M J Martínez Urrutia; R Lobato; E Jaureguizar
Journal:  Curr Urol Rep       Date:  2014-08       Impact factor: 3.092

Review 4.  A rare cause of esophagopleural fistula due to intensity-modulated proton therapy: a case report and review of literature.

Authors:  Osman Ali; Suryanarayana Reddy Challa; Osman M Siddiqui; Sukaina Ali; Raymond E Kim
Journal:  Clin J Gastroenterol       Date:  2021-04-27

5.  Outcomes of seromuscular bladder augmentation compared with standard bladder augmentation in the treatment of children with neurogenic bladder.

Authors:  Xiao-Gang Sun; Yan-Xia Li; Long-Fei Ji; Jia-Long Xu; Wei-Xiu Chen; Ruo-Yi Wang
Journal:  World J Clin Cases       Date:  2022-08-16       Impact factor: 1.534

6.  A case of tubular adenoma developing after bladder augmentation: Case report and literature review.

Authors:  Yutaka Hayashi; Satoko Shiyanagi; Itsuro Nagae; Tetsuo Ishizaki; Kazuhiko Kasuya; Kenji Katsumata; Atsuyuki Yamataka; Akihiko Tsuchida
Journal:  Int J Surg Case Rep       Date:  2015-12-11
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.